Clinical Trial Update: A Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers

View source ↗

Summary

This update reports the termination of a follow-up study of the GBS-NN/NN2 vaccine in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcus Infection

Drugs mentioned

• GBS-NN/NN2 vaccine (GBS-NN/NN2 vaccine)

Snippet

Sponsor: Minervax ApS | Conditions: Group B Streptococcus Infection | Status: TERMINATED